Biosynex Pharma Benelux(SRL)

BE 0787.324.947

	2023		2022
Profit/Loss Section 9904: Profit/Loss of the financial year (after taxes on result) (+/-)	€ -764.494	-315%	€ 355.952
Turnover Section 70: Turnover of the financial year	€ 1.402.154	> 1.000%	€ 11.163
Equity Section 10/15: Equity consists of capital, capital reserves and earnings that remain within the company. These are fully owned by the company and are at its disposal to cover its risks. The better the ratio between equity and debts, the more solvent a company is. A positive equity ratio is important. A negative equity ratio (because of accumulated losses) is a severe warning sign that the continuity of the company may be threatened.	€ 3.091.458	-20%	€ 3.855.952
Gross margin Section 9900: Gross margin or added value is net sales minus the direct costs of the goods sold. In other words: sales invoices minus purchase invoices (70/74 – 60/61). A negative gross margin is a warning sign especially when occurring over several years. It may indicate that the company has insufficient means to cover internal costs like salaries, etc.	€ 70.108	-89%	€ 644.451
Employees Section 9087: Average number of staff in full time equivalents	6		0

	Date	Publication
	20-06-2022	Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

What is the VAT number of Biosynex Pharma Benelux?

The VAT number of Biosynex Pharma Benelux is BE0787324947.

When was Biosynex Pharma Benelux founded?

Biosynex Pharma Benelux was founded on 16-06-2022.

What is the address of Biosynex Pharma Benelux?

The current registered office of Biosynex Pharma Benelux is located at Avenue du Boulevard 21/b8, 1210 Saint-Josse-ten-Noode.

When was the last time Biosynex Pharma Benelux filed their annual financial statements?

The most recent financial statements of Biosynex Pharma Benelux were filed on 19-07-2024. You can view them here.

How many employees does Biosynex Pharma Benelux have?

There are 6 FTEs working at Biosynex Pharma Benelux according to the staff figures in the most recent financial statements.

What is the annual turnover of Biosynex Pharma Benelux?

At the time of its most recent financial statements, Biosynex Pharma Benelux recorded a total turnover of €1,402,154.50.